151 related articles for article (PubMed ID: 37967657)
1. Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment.
Passos JS; Apolinario AC; Ishida K; Martins TS; Lopes LB
Eur J Pharm Sci; 2024 Jan; 192():106638. PubMed ID: 37967657
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.
Kumbhar PS; Manjappa AS; Shah RR; Nadaf SJ; Disouza JI
AAPS PharmSciTech; 2023 Apr; 24(5):106. PubMed ID: 37085596
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
Rajinikanth PS; Chellian J
Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
[No Abstract] [Full Text] [Related]
5. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
7. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study.
Czajkowska-Kośnik A; Szymańska E; Winnicka K
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615429
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
10. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
[TBL] [Abstract][Full Text] [Related]
11. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
[No Abstract] [Full Text] [Related]
12. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
[TBL] [Abstract][Full Text] [Related]
13. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic Iron Oxide-Loaded Lipid Nanocarriers Incorporated in Thermosensitive In Situ Gel for Magnetic Brain Targeting of Clonazepam.
Abbas H; Refai H; El Sayed N
J Pharm Sci; 2018 Aug; 107(8):2119-2127. PubMed ID: 29665379
[TBL] [Abstract][Full Text] [Related]
15. Amphiphilic NLC-Gel formulation loaded with Sebacoyl dinalbuphine ester and Nalbuphine for localized postoperative pain management.
Lin CL; Li YL; Chen YW; Kuo CH; Tu TY; Liu YF; Tsai JC; Shyong YJ
Int J Pharm; 2024 Jun; 659():124295. PubMed ID: 38823469
[TBL] [Abstract][Full Text] [Related]
16. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW
Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481
[TBL] [Abstract][Full Text] [Related]
17. Gel-Dispersed Nanostructured Lipid Carriers Loading Thymol Designed for Dermal Pathologies.
Folle C; Marqués AM; Díaz-Garrido N; Carvajal-Vidal P; Sánchez López E; Suñer-Carbó J; Halbaut L; Mallandrich M; Espina M; Badia J; Baldoma L; García ML; Calpena AC
Int J Nanomedicine; 2024; 19():1225-1248. PubMed ID: 38348173
[TBL] [Abstract][Full Text] [Related]
18. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
[TBL] [Abstract][Full Text] [Related]
19. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.
Youssef AAA; Dudhipala N; Majumdar S
Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
